X-118974796-A-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001031855.3(LONRF3):ā€‹c.16A>Gā€‹(p.Ile6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000063 in 1,205,583 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000036 ( 0 hom., 1 hem., cov: 24)
Exomes š‘“: 0.000066 ( 0 hom. 25 hem. )

Consequence

LONRF3
NM_001031855.3 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.702
Variant links:
Genes affected
LONRF3 (HGNC:21152): (LON peptidase N-terminal domain and ring finger 3) The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. Multiple alternatively spliced transcript variants have been suggested, but their full length natures are not clear. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04655218).
BS2
High Hemizygotes in GnomAdExome4 at 25 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LONRF3NM_001031855.3 linkuse as main transcriptc.16A>G p.Ile6Val missense_variant 1/11 ENST00000371628.8 NP_001027026.1 Q496Y0-1A8K2D3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LONRF3ENST00000371628.8 linkuse as main transcriptc.16A>G p.Ile6Val missense_variant 1/111 NM_001031855.3 ENSP00000360690.3 Q496Y0-1
LONRF3ENST00000304778.11 linkuse as main transcriptc.16A>G p.Ile6Val missense_variant 1/101 ENSP00000307732.7 Q496Y0-2
LONRF3ENST00000481285.5 linkuse as main transcriptn.16A>G non_coding_transcript_exon_variant 1/112 ENSP00000435426.1 Q496Y0-3

Frequencies

GnomAD3 genomes
AF:
0.0000357
AC:
4
AN:
112024
Hom.:
0
Cov.:
24
AF XY:
0.0000292
AC XY:
1
AN XY:
34234
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000566
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000363
AC:
6
AN:
165223
Hom.:
0
AF XY:
0.0000180
AC XY:
1
AN XY:
55587
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000381
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000701
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000658
AC:
72
AN:
1093559
Hom.:
0
Cov.:
29
AF XY:
0.0000694
AC XY:
25
AN XY:
359971
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000287
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000809
Gnomad4 OTH exome
AF:
0.0000436
GnomAD4 genome
AF:
0.0000357
AC:
4
AN:
112024
Hom.:
0
Cov.:
24
AF XY:
0.0000292
AC XY:
1
AN XY:
34234
show subpopulations
Gnomad4 AFR
AF:
0.0000324
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000566
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 04, 2023The c.16A>G (p.I6V) alteration is located in exon 1 (coding exon 1) of the LONRF3 gene. This alteration results from a A to G substitution at nucleotide position 16, causing the isoleucine (I) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
4.0
DANN
Benign
0.74
DEOGEN2
Benign
0.012
.;T
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.56
T;T
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.047
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.34
N;N
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.15
N;N
REVEL
Benign
0.19
Sift
Benign
0.072
T;T
Sift4G
Benign
0.28
T;T
Polyphen
0.0
B;B
Vest4
0.035
MutPred
0.090
Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);
MVP
0.43
MPC
0.32
ClinPred
0.036
T
GERP RS
-9.0
Varity_R
0.043
gMVP
0.063

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs755679459; hg19: chrX-118108759; API